Evidence map›Paper›PMID 40226807›Full record

ArticleToxicology reports2025

Histopathological evaluation of viscoelastic POSS administered subcutaneously using a rat model.

Hamed Benghuzzi, Michelle Tucci, Drew Hildebrandt, Sukhendu Hait, Joseph Lichtenhan

Abstract read
In one paragraph

Article in Toxicology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Liquid Trisilanol i-Octyl POSS Achieves Rapid Hemostasis and Pneumostasis in Experimental Lung Injury.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hamed BenghuzziJackson State University, 1400 John R. Lynch St, Jackson, MS 39217, USA.
Michelle TucciUniversity of Mississippi Medical Center, 2500 North State Street, Jackson, MS, USA.
Drew HildebrandtUniversity of Mississippi Medical Center, 2500 North State Street, Jackson, MS, USA.
Sukhendu HaitHybrid Plastics, 55 Wl Runnels Industrial Dr, Hattiesburg, MS 39401, USA.
Joseph LichtenhanHybrid Plastics, 55 Wl Runnels Industrial Dr, Hattiesburg, MS 39401, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Polyhedral oligomeric silsesquioxanes (POSS), have a structure resembling a cage in which the corners are silicon atoms bound with oxygen bridges. POSS cages may be dissolved in a polymer matrix or used as a cross-linker. When added into a polymer matrix, they remain non-toxic, improve mechanical properties, and resist biodegradation, which is important in tissue engineering. Limited studies evaluate long-term tissue responses to POSS gels. Methods: Adult male Sprague Dawley rat were used as a model to determine the tissue response towards multiple dosing of POSS gel compared to air injections for up to 180 days. A total of twenty-four rats was used for the study (Six rats were injected with the fluorescently labeled UVPOSS:POSS for imaging and eighteen additional rats were injected either with POSS SO1455 or air as a control group). Each group received three injections, and tissues were harvested 7, 14, and 21 days for early tissue responses, and 90- and 180-days post injection for late tissue reactions. Results: POSS vesicles formed after injection and remained pliable over 180 days. POSS complexed with Perylene dye could be imaged over 4 weeks showing lack of systemic mobility. Over the course of 180 days, POSS triggered a foreign body response with low- grade inflammation. The high viscosity nature of POSS resulted in the formation of a dense capsule preventing the material migration.

Indexed as

HistopathologyIn Vivo Imaging Systems, IVIS®Polyhedral oligomeric silsesquioxanePOSS

Identifiers

PMID40226807
PMCPMC11986480

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.